Neave Me Corcoran, Frances S Mair, Barbara Nicholl, Sara Macdonald, Bhautesh Dinesh Jani
{"title":"Long-term conditions, multimorbidity and colorectal cancer risk in the UK Biobank cohort.","authors":"Neave Me Corcoran, Frances S Mair, Barbara Nicholl, Sara Macdonald, Bhautesh Dinesh Jani","doi":"10.1177/26335565221110123","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Early identification of colorectal cancer (CRC) is an international priority. Multimorbidity (presence of ≥2 long-term conditions (LTCs)) is increasing and the relationship between CRC and LTCs is little-understood. This study explores the relationship between individual LTCs, multimorbidity and CRC incidence and mortality.</p><p><strong>Methods: </strong>Longitudinal analysis of the UK Biobank cohort, participants recruited 2006-2010; <i>N</i> = 500,195; excluding previous CRC at baseline. Baseline data was linked with cancer/mortality registers. Demographic characteristics, lifestyle factors, 43 LTCs, CRC family history, non-CRC cancers, and multimorbidity count were recorded. Variable selection models identified candidate LTCs potentially predictive of CRC outcomes and Cox regression models tested for significance of associations between selected LTCs and outcomes.</p><p><strong>Results: </strong>Participants' age range: 37-73 (mean age 56.5; 54.5% female). CRC was diagnosed in 3669 (0.73%) participants, and 916 (0.18%) died from CRC during follow-up (median follow-up 7 years). CRC incidence was higher in the presence of heart failure (Hazard Ratio (HR) 1.96, 95% Confidence Interval (CI) 1.13-3.40), diabetes (HR 1.15, CI 1.01-1.32), glaucoma (HR 1.36, CI 1.06-1.74), male cancers (HR 1.44, CI 1.01-2.08). CRC mortality was higher in presence of epilepsy (HR 1.83, CI 1.03-3.26), diabetes (HR 1.32, CI 1.02-1.72), osteoporosis (HR 1.67, CI 1.12-2.58). No significant association was found between multimorbidity (≥2 LTCs) and CRC outcomes.</p><p><strong>Conclusions: </strong>The associations of certain LTCs with CRC incidence and mortality has implications for clinical practice: presence of certain LTCs in patients presenting with CRC symptoms could trigger early investigation and diagnosis. Future research should explore causative mechanisms and patient perspectives.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"12 ","pages":"26335565221110123"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/dd/26/10.1177_26335565221110123.PMC9483970.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of multimorbidity and comorbidity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26335565221110123","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Purpose: Early identification of colorectal cancer (CRC) is an international priority. Multimorbidity (presence of ≥2 long-term conditions (LTCs)) is increasing and the relationship between CRC and LTCs is little-understood. This study explores the relationship between individual LTCs, multimorbidity and CRC incidence and mortality.
Methods: Longitudinal analysis of the UK Biobank cohort, participants recruited 2006-2010; N = 500,195; excluding previous CRC at baseline. Baseline data was linked with cancer/mortality registers. Demographic characteristics, lifestyle factors, 43 LTCs, CRC family history, non-CRC cancers, and multimorbidity count were recorded. Variable selection models identified candidate LTCs potentially predictive of CRC outcomes and Cox regression models tested for significance of associations between selected LTCs and outcomes.
Results: Participants' age range: 37-73 (mean age 56.5; 54.5% female). CRC was diagnosed in 3669 (0.73%) participants, and 916 (0.18%) died from CRC during follow-up (median follow-up 7 years). CRC incidence was higher in the presence of heart failure (Hazard Ratio (HR) 1.96, 95% Confidence Interval (CI) 1.13-3.40), diabetes (HR 1.15, CI 1.01-1.32), glaucoma (HR 1.36, CI 1.06-1.74), male cancers (HR 1.44, CI 1.01-2.08). CRC mortality was higher in presence of epilepsy (HR 1.83, CI 1.03-3.26), diabetes (HR 1.32, CI 1.02-1.72), osteoporosis (HR 1.67, CI 1.12-2.58). No significant association was found between multimorbidity (≥2 LTCs) and CRC outcomes.
Conclusions: The associations of certain LTCs with CRC incidence and mortality has implications for clinical practice: presence of certain LTCs in patients presenting with CRC symptoms could trigger early investigation and diagnosis. Future research should explore causative mechanisms and patient perspectives.
目的:早期识别结直肠癌(CRC)是一个国际优先事项。多重发病(存在≥2个长期疾病(LTCs))正在增加,CRC和LTCs之间的关系尚不清楚。本研究探讨了个体LTCs、多发病与CRC发病率和死亡率之间的关系。方法:对2006-2010年招募的英国生物银行队列进行纵向分析;N = 500,195;不包括以前的基线CRC。基线数据与癌症/死亡率登记相关联。记录人口统计学特征、生活方式因素、43例LTCs、结直肠癌家族史、非结直肠癌及多病计数。变量选择模型确定候选LTCs可能预测CRC结局,Cox回归模型检验所选LTCs与结局之间的相关性。结果:参与者年龄范围:37 ~ 73岁(平均年龄56.5岁;54.5%的女性)。3669名(0.73%)参与者被诊断为结直肠癌,916名(0.18%)参与者在随访期间(中位随访7年)死于结直肠癌。存在心力衰竭时CRC的发病率更高(风险比(HR) 1.96, 95%可信区间(CI) 1.13-3.40),糖尿病(HR 1.15, CI 1.01-1.32),青光眼(HR 1.36, CI 1.06-1.74),男性癌症(HR 1.44, CI 1.01-2.08)。癫痫(HR 1.83, CI 1.03-3.26)、糖尿病(HR 1.32, CI 1.02-1.72)、骨质疏松症(HR 1.67, CI 1.12-2.58)存在结直肠癌死亡率较高。多重发病(≥2个LTCs)与CRC结局之间未发现显著关联。结论:某些LTCs与CRC发病率和死亡率的关联对临床实践具有重要意义:在出现CRC症状的患者中存在某些LTCs可以引发早期调查和诊断。未来的研究应探索病因机制和患者观点。